Aspirion completes acquisition of Boost Healthcare to enhance revenue cycle management capabilities
Acquiring Company
Aspirion
Acquired Company
Boost Healthcare
ColumbusAlamedaHealth CareHealth CareDescription
Aspirion, the healthcare technology revenue cycle management leader, has announced the acquisition of Boost Healthcare. This strategic acquisition marks an expansion of Aspirion's mission to secure rightful reimbursement for healthcare providers through innovative technology solutions.
Quick answer
Aspirion is acquiring Boost Healthcare, announced December 18, 2024. Aspirion is based in Columbus, Georgia, United States.
- How much did Aspirion pay for Boost Healthcare?
- The deal value was not disclosed.
- What does Aspirion do?
- Aspirion, headquartered in Columbus, GA, helps hospitals and physicians recover otherwise lost claims revenue from Motor Vehicle Accidents, Workers' Compensation, Veterans Affairs, and TRICARE as well as out-of-state..
- Where are Aspirion and Boost Healthcare based?
- Aspirion is based in Columbus, Georgia, United States. Boost Healthcare is based in Alameda, California, United States.
- Who are the decision-makers at Aspirion?
- Fundz holds 1 contact at Aspirion. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Health Care and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- PAX Health completes acquisition of Harris Psychiatric Services, expanding specialized mental health care for workplace and accident recovery (January 27, 2025)
- Exicure, Inc. completes acquisition of GPCR Therapeutics USA Inc. to enhance its pipeline for cell and gene therapies (January 22, 2025)
- Revelation Pharma strengthens its nationwide presence in ENT and Animal Health with acquisition of Cascade Specialty Pharmacy (January 22, 2025)
- Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio (January 13, 2025)
- Quanterix Corporation to acquire Akoya Biosciences, creating a groundbreaking integrated solution for ultra-sensitive detection of protein biomarkers (January 10, 2025)
- Anatomage Inc. completes acquisition of BioDigital to expand medical education technology offerings (January 10, 2025)
Who to call at Aspirion, and when
When Aspirion changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Aspirion raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aspirion, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aspirion. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aspirion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Boost Healthcare?
Boost Healthcare was acquired by Aspirion, based in Columbus. The deal was reported on December 18, 2024. Aspirion is privately held and operates in Health Care.
When did Aspirion acquire Boost Healthcare?
Aspirion's acquisition of Boost Healthcare was reported on December 18, 2024. Aspirion, the healthcare technology revenue cycle management leader, has announced the acquisition of Boost Healthcare. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Boost Healthcare do?
Boost Healthcare, an aspirion company, is a firm focused on helping healthcare providers identify and recover revenue. Our team works to improve overall revenue by recovering denied and underpaid claims from commercial and government payers. It is privately held, operating in Health Care, and is based in Alameda.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.